BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32033719)

  • 1. Post-finasteride syndrome: a surmountable challenge for clinicians.
    Traish AM
    Fertil Steril; 2020 Jan; 113(1):21-50. PubMed ID: 32033719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Lee S; Lee YB; Choe SJ; Lee WS
    Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent sexual side effects of finasteride: could they be permanent?
    Irwig MS
    J Sex Med; 2012 Nov; 9(11):2927-32. PubMed ID: 22789024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.
    Chiriacò G; Cauci S; Mazzon G; Trombetta C
    Andrology; 2016 Mar; 4(2):245-50. PubMed ID: 26763726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent sexual side effects of finasteride for male pattern hair loss.
    Irwig MS; Kolukula S
    J Sex Med; 2011 Jun; 8(6):1747-53. PubMed ID: 21418145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
    Said MA; Mehta A
    Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
    Coskuner ER; Ozkan B; Culha MG
    Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?
    Traish AM; Melcangi RC; Bortolato M; Garcia-Segura LM; Zitzmann M
    Rev Endocr Metab Disord; 2015 Sep; 16(3):177-98. PubMed ID: 26296373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Fertig RM; Gamret AC; Darwin E; Gaudi S
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Depression Associated With Finasteride Treatment.
    Pompili M; Magistri C; Maddalena S; Mellini C; Persechino S; Baldessarini RJ
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):304-309. PubMed ID: 33814544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-finasteride syndrome - does it really exist?
    Maksym RB; Kajdy A; Rabijewski M
    Aging Male; 2019 Dec; 22(4):250-259. PubMed ID: 30651009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
    Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
    J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.
    Di Loreto C; La Marra F; Mazzon G; Belgrano E; Trombetta C; Cauci S
    PLoS One; 2014; 9(6):e100237. PubMed ID: 24959691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
    Ali AK; Heran BS; Etminan M
    Pharmacotherapy; 2015 Jul; 35(7):687-95. PubMed ID: 26133534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
    Ganzer CA; Jacobs AR; Iqbal F
    Am J Mens Health; 2015 May; 9(3):222-8. PubMed ID: 24928450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
    Arias-Santiago S; Camacho-Martínez FM
    Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations of gut microbiota composition in post-finasteride patients: a pilot study.
    Borgo F; Macandog AD; Diviccaro S; Falvo E; Giatti S; Cavaletti G; Melcangi RC
    J Endocrinol Invest; 2021 Jun; 44(6):1263-1273. PubMed ID: 32951160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
    Gupta MA; Vujcic B; Gupta AK
    Skinmed; 2020; 18(3):146-150. PubMed ID: 32790610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.